The global bladder scanners market size was valued at USD 177.3 million in 2025 and is projected to grow from USD 187.88 million in 2026 to USD 298.78 million by 2034, registering a CAGR of 5.97% during the forecast period from 2026 to 2034. North America dominated the bladder scanners market with a 38.2% market share in 2025.
Bladder scanners are portable, non-invasive ultrasound devices that measure bladder volume and assess urinary retention by providing real-time images of the bladder without catheterization. These devices allow healthcare professionals to quickly check whether the bladder is emptying properly and identify patients who may require further treatment. Their simple and painless scanning process makes them useful across hospitals, clinics, rehabilitation centers, and long-term care facilities. Bladder scanners also help reduce unnecessary catheter use, improve patient comfort, and support faster clinical decisions in routine urinary care.
Download a Free Sample To learn more about this report,
AI-Based Automation Transforming Bladder Volume Assessment
The need for faster and more consistent bedside bladder assessment is encouraging the use of AI-enabled scanning functions in the Bladder Scanners Market. This shift is moving devices toward automated bladder detection, anatomical guidance, and volume calculation, which reduces operator dependence and supports more standardized measurements across care settings. Systems such as the EchoNous Kosmos Bladder illustrate this transition by using AI-assisted imaging to simplify bladder volume assessment at the point of care.
3D Bladder Imaging Gaining Importance
The need for more accurate post-void residual and urinary-retention assessment is supporting a transition from basic volume estimation toward 3D bladder imaging. This development allows scanners to capture the bladder from multiple planes and generate more complete volumetric measurements, improving consistency in clinical decision-making. 3D bladder scanners are now widely used in urology, postoperative care, rehabilitation, and geriatric settings where repeated non-invasive volume checks help reduce unnecessary catheterization.
Higher Prevalence of Urinary Retention and Lower Urinary Tract Disorders and Greater Need to Reduce Unnecessary Urinary Catheterization Drive Market
A higher prevalence of urinary retention, benign prostatic hyperplasia, neurogenic bladder, and other lower urinary tract disorders expands the patient pool requiring bladder-volume assessment. Greater diagnostic activity in urology, postoperative care, rehabilitation, and geriatric settings increases demand for non-invasive bladder scanners. Hospitals commonly use bladder scanning to measure post-void residual urine before deciding whether catheterization or further urological evaluation is necessary. A broader clinical need for repeated bladder assessment therefore supports device demand and encourages suppliers to expand portable scanner availability across care settings.
A stronger focus on reducing avoidable catheter use increases the need for bladder scanners that help clinicians confirm urinary retention before catheter insertion. Lower catheter utilization can reduce patient discomfort and exposure to catheter-associated urinary tract infections, which makes non-invasive assessment more valuable in hospital protocols. Emergency departments, surgical wards, and nursing units increasingly use bladder scans to guide decisions on intermittent or indwelling catheterization. Wider adoption of catheter-reduction practices therefore strengthens demand for bladder scanners and supports broader procurement across acute and long-term care facilities.
High Cost of Advanced Bladder Scanning Systems and Limited Reimbursement and Budget Constraints
High acquisition costs for bladder scanners with 3D imaging, automated volume measurement, and advanced software increase the capital burden on healthcare facilities. Smaller hospitals, clinics, and long-term care centers may delay purchases when budgets remain limited. This cost barrier restricts wider adoption and slows market penetration, particularly in price-sensitive healthcare systems.
Limited reimbursement coverage reduces the financial incentive for healthcare providers to invest in dedicated bladder scanning equipment. Hospitals with restricted capital budgets may prioritize essential diagnostic and treatment devices over bladder scanners. This spending pressure delays procurement and replacement cycles, limiting broader market growth.
Development of Pediatric and Geriatric-Specific Bladder Scanning Solutions and Wider Adoption in Rehabilitation Centers and Postoperative Care Units Offers Growth Opportunities
Medical device manufacturers, pediatric hospitals, geriatric care providers, and urology clinics can benefit from bladder scanners designed around age-specific anatomy and clinical needs. Specialized devices can open revenue through premium product lines, dedicated probes, software packages, and service contracts for pediatric and elderly care settings. Companies such as Verathon and Laborie already serve bladder volume assessment applications across hospital and urology environments.
Rehabilitation centers, surgical hospitals, recovery units, and nursing facilities can benefit from routine bladder volume assessment during recovery and mobility-limited care. Broader use in these settings can create revenue through device placements, consumables, maintenance contracts, and recurring training or support services. Portable bladder scanner suppliers such as Verathon and dBMEDx are positioned to serve these point-of-care applications.
Blood Compatibility and Clotting Management Complicate Device Development and Supply Constraints for Critical Oxygenator Components Hinders Growth
Blood contact with artificial lung membranes can trigger clot formation, while anticoagulation used to control this risk can contribute to bleeding complications. These competing risks make membrane design, clinical management, and product development more complex and can slow wider adoption of artificial lung systems. Recent ECMO evidence continues to identify bleeding and thrombosis among the most important complications of extracorporeal support.
Artificial lung manufacturers depend on specialized oxygenators, membranes, pumps, sensors, and other medical-grade components that require strict quality control and reliable supply. Component shortages can limit production volumes, disrupt hospital availability, and make it difficult for companies to expand commercially. A real-life example is the U.S. FDA's June 2026 update extending shortages of extracorporeal-circulation oxygenator devices into the first quarter of 2027.
The bench top/portable bladder scanners segment dominated the bladder scanners market with a market share of 58.6% in 2025, supported by their widespread use across hospitals, clinics, and diagnostic settings for non-invasive bladder volume assessment. Their portability, ease of use, and suitability for routine bedside examinations continue to support strong adoption.
The handheld bladder scanner segment is expected to grow at a CAGR of 9.5% during the forecast period 2026–2034, supported by demand for compact devices that improve mobility, point-of-care assessment, and ease of use across different clinical environments.
Request Customizationto receive a tailored report.
The urology segment dominated the bladder scanners market with a market share of 54.3% in 2025, supported by the frequent use of bladder scanning for urinary retention assessment, post-void residual measurement, and management of lower urinary tract conditions. Its established role in routine urological diagnosis and patient monitoring strengthens the segment’s leading position.
The spinal cord injury segment is expected to grow at a CAGR of 9.1% during the forecast period 2026–2034, supported by the need for regular bladder monitoring in patients with neurogenic bladder dysfunction and reduced reliance on unnecessary catheterization. The gynecology segment remains important for pelvic care, postoperative monitoring, and assessment of urinary complications associated with gynecological procedures.
The hospitals & clinics segment dominated the bladder scanners market with a market share of 57.4% in 2025, supported by high patient volumes, availability of trained healthcare professionals, and routine use of bladder scanning across emergency, urology, postoperative, and inpatient care settings. Their ability to integrate bladder scanners into regular clinical workflows continues to support adoption.
The ambulatory surgical centers segment is expected to grow at a CAGR of 9.4% during the forecast period 2026–2034, supported by the need for rapid bladder assessment before and after outpatient surgical procedures and timely patient discharge. Diagnostic centers use bladder scanners for non-invasive assessment and follow-up services, while the others segment includes rehabilitation centers, long-term care facilities, and other healthcare settings where bladder volume monitoring supports patient management.
Speak to an Analystto discuss market opportunities.
North America accounted for the largest share of the bladder scanners market at 38.2% in 2025. The region’s strong market position reflects broad clinical use of non-invasive bladder scanning, advanced healthcare facilities, and wide availability of portable diagnostic systems. The U.S. bladder scanners market is supported by an expanding elderly population, as the U.S. Census Bureau projects the population aged 65 and older to reach 73.1 million by 2030 and 94.7 million by 2060, potentially increasing the volume of patients requiring bladder-volume assessment and urinary-retention monitoring.
The Canada bladder scanners market is similarly shaped by demographic change, with Statistics Canada projecting the share of people aged 65 and older to increase from 19.5% in 2025 to between 22.6% and 32.5% by 2075, which may strengthen the need for bladder monitoring across hospitals, long-term care facilities, and community-based care settings.
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia-Pacific bladder scanners market is expected to grow at the fastest CAGR of 10.2% during the forecast period 2026–2034. Market growth is supported by expanding healthcare infrastructure, wider access to urological diagnostic services, and broader adoption of non-invasive bladder assessment across hospitals and specialty care settings. The Japan bladder scanners market is supported by demographic ageing, as Japan’s National Institute of Population and Social Security Research (IPSS) projects people aged 65 years and above to account for 34.8% of the country’s population by 2040, compared with 28.6% in 2020, reinforcing the need for geriatric bladder assessment and urinary-retention management.
The China bladder scanners market is also influenced by population ageing, with the National Health Commission projecting the country’s population aged 60 years and above to exceed 400 million by around 2035 and account for more than 30% of the total population, placing greater pressure on hospitals and urology services to manage age-related urinary conditions efficiently.
The Europe bladder scanners market accounted for a market share of 27.1% in 2025 and is expected to grow at a CAGR of 8.1% during the forecast period 2026–2034. Growth is supported by higher clinical focus on urinary retention management and wider use of bladder scanners in postoperative care, urology departments, rehabilitation centers, and long-term care facilities. The U.K. bladder scanners market is supported by demographic ageing, as the Office for National Statistics (ONS) projects the population aged 85 years and above to nearly double from 1.7 million in 2022 to 3.3 million by 2047, potentially increasing the need for non-invasive bladder monitoring among very elderly patients.
The Germany bladder scanners market also benefits from an ageing population, with Destatis projecting the population aged 80 years and above to increase from 6.1 million in 2024 to around 8.5–9.8 million by 2050, supporting greater utilization of bladder scanning across hospitals and elderly-care settings. The France bladder scanners market is similarly influenced by demographic shifts, as INSEE’s 2026 population projections indicate that France is expected to have 49 people aged 65 years and above for every 100 people aged 20–64 by 2040, compared with 40 in 2026, pointing to a larger need for age-related urological assessment and continence care.
The bladder scanners market is moderately fragmented, with established medical device manufacturers, diagnostic imaging companies, specialized urology equipment providers, and smaller technology-focused firms operating across global and regional markets. Established players compete mainly on measurement accuracy, product reliability, clinical validation, brand reputation, distribution reach, and integration with hospital workflows. Verathon Inc., LABORIE Medical Technologies, GE HealthCare, Becton Dickinson & Company, and Mindray Bio-Medical Electronics are among the leading players in the bladder scanners market, collectively accounting for approximately 45-50% of the global market share.
Emerging and regional players focus more on competitive pricing, portable and user-friendly designs, faster product customization, and targeted solutions for clinics, rehabilitation centers, and smaller healthcare facilities. Competition also centers on technological differentiation, ease of use, after-sales support, and the ability to meet regulatory and procurement requirements across different healthcare settings.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Cochlear Implants Market Size, Share, Growth, Forecast, 2034
Fluoroscopy Equipment Market Size, Share, Growth, Analysis, 2034
Endoscopes Market Size, Share, Growth, Analysis, Report, 2034
Acute Wound Care Market Size, Share, Growth, Forecast, 2034
Digital Therapeutics Market Size, Share, Growth, Analysis, 2034
Breast Reconstruction Market Size, Share, Growth, Analysis, 2034
We are featured on:
sales@straitsresearch.com